Enrollment strategies in the era of digital revolution: Experience from a remote health management program.

Autor: Hassan S; Accelerator for Clinical Transformation, Brigham and Women's Hospital, Boston, MA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA. Electronic address: shassan12@mgb.org., Chang LS; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA., Gabovitch D; Accelerator for Clinical Transformation, Brigham and Women's Hospital, Boston, MA., Chasse J; Accelerator for Clinical Transformation, Brigham and Women's Hospital, Boston, MA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA., Stern G; Division of Pharmacy, Brigham and Women's Hospital, Boston, MA., Colling C; Division of Endocrinology, Diabetes and Hypertension, Massachusetts General Hospital, Boston, MA., Zelle D; Accelerator for Clinical Transformation, Brigham and Women's Hospital, Boston, MA., Cannon CP; Accelerator for Clinical Transformation, Brigham and Women's Hospital, Boston, MA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA., Wexler D; Division of Endocrinology, Diabetes and Hypertension, Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA., Scirica BM; Accelerator for Clinical Transformation, Brigham and Women's Hospital, Boston, MA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA., Blood AJ; Accelerator for Clinical Transformation, Brigham and Women's Hospital, Boston, MA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA.
Jazyk: angličtina
Zdroj: American heart journal [Am Heart J] 2024 Dec; Vol. 278, pp. 181-185. Date of Electronic Publication: 2024 Sep 18.
DOI: 10.1016/j.ahj.2024.09.005
Abstrakt: We describe the strategies used to identify and enroll participants in a remote health management program aimed at optimizing diabetes care in patients at high cardiovascular and kidney risk. Using a combination of digital and traditional outreach methods, including patient portals, emails, mailed letters, and provider referrals, we successfully enrolled 200 participants. Our experience highlights the effectiveness of a hybrid approach in achieving enrollment targets, addressing the challenges of identification of eligible candidates and engagement while integrating traditional methods for inclusivity.
Competing Interests: Declaration of competing interest Lee-Shing Chang: Applied Therapeutics, Better Therapeutics, Boehringer Ingelheim, Corcept Therapeutics, Eli Lilly, Fractyl Health, Novo Nordisk, Rhythm Pharmaceuticals, Sanofi Christopher Cannon: Research Grants – Amgen, Better Therapeutics, Boehringer Ingelheim, Daiichi Sankyo, Merck, Novo Nordisk, Pfizer; Consulting – Amryt/Chiesi, Alnylam, Amarin, Amgen, Applied Therapeutics, Ascendia, Biogen, Boehringer Ingelheim, Bristol Myers-Squibb, CSL Behring, Eli Lilly, Janssen, Lexicon, Merck, Milestone, Pfizer, Rhoshan, Sanofi Deborah Wexler: Novo Nordisk, Vertex Benjamin M. Scirica: Research Grants – Better Therapeutics, Boehringer Ingelheim, Merck, NovoNordisk, and Pfizer. Consulting – Abbvie (DSMB), AstraZeneca (DSMB), Boehringer Ingelheim, Better Therapeutics, Bristol Myers-Squibb, Elsevier Practice Update Cardiology, Esperion, Hanmi (DSMB), Lexeo (DSMB), Lexicon, NovoNordisk; Equity – Health [at] Scale and Doximity. Alexander J. Blood: Research Grants – Boehringer Ingelheim, Novo Nordisk, Eli Lilly, General Electric Health; Consulting – Medscape, Novo Nordisk,Milestone Therapeutics, Walgreens, Color Health, Arsenal Capital Partners; Equity – Knownwell Other authors have no disclosures.
(Copyright © 2024 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: